rituximab
Not Tagged
['ritux']
northend et al
asym foll lymp low tumour burden
value of ritux maintenance (2yr)
phase3 n=463
r-maint v r-induction vs w+w
med fu 12yr
r-maint ttnt: med not reached v 10yr v 3yr
at 10yr: no treatment in 65% v 49% v 29% #ash2022 